Baldwin Wealth Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-350
| Closed | -$177K | – | 605 |
|
|
2024
Q3 | $177K | Buy |
350
+268
| +327% | +$135K | 0.01% | 348 |
|
|
2024
Q2 | $40K | Sell |
82
-20
| -20% | -$9.74K | ﹤0.01% | 380 |
|
|
2024
Q1 | $55.1K | Hold |
102
| – | – | ﹤0.01% | 356 |
|
|
2023
Q4 | $56.6K | Hold |
102
| – | – | ﹤0.01% | 362 |
|
|
2023
Q3 | $44.6K | Hold |
102
| – | – | ﹤0.01% | 411 |
|
|
2023
Q2 | $51.2K | Sell |
102
-3,162
| -97% | -$1.59M | ﹤0.01% | 412 |
|
|
2023
Q1 | $1.63M | Sell |
3,264
-172
| -5% | -$86K | 0.14% | 97 |
|
|
2022
Q4 | $1.4M | Sell |
3,436
-370
| -10% | -$151K | 0.13% | 103 |
|
|
2022
Q3 | $1.24M | Sell |
3,806
-29
| -0.8% | -$9.45K | 0.17% | 60 |
|
|
2022
Q2 | $1.35M | Sell |
3,835
-571
| -13% | -$200K | 0.17% | 62 |
|
|
2022
Q1 | $2.41M | Sell |
4,406
-801
| -15% | -$438K | 0.26% | 55 |
|
|
2021
Q4 | $3.43M | Buy |
5,207
+239
| +5% | +$157K | 0.34% | 49 |
|
|
2021
Q3 | $3.09M | Sell |
4,968
-296
| -6% | -$184K | 0.34% | 49 |
|
|
2021
Q2 | $3.32M | Sell |
5,264
-1,039
| -16% | -$656K | 0.36% | 49 |
|
|
2021
Q1 | $3.08M | Sell |
6,303
-3,039
| -33% | -$1.49M | 0.37% | 48 |
|
|
2020
Q4 | $4.67M | Sell |
9,342
-5,910
| -39% | -$2.95M | 0.59% | 48 |
|
|
2020
Q3 | $6M | Sell |
15,252
-271
| -2% | -$107K | 0.82% | 39 |
|
|
2020
Q2 | $5.13M | Sell |
15,523
-689
| -4% | -$227K | 0.75% | 42 |
|
|
2020
Q1 | $3.93M | Buy |
16,212
+1,725
| +12% | +$418K | 0.69% | 47 |
|
|
2019
Q4 | $3.78M | Buy |
14,487
+6,235
| +76% | +$1.63M | 0.53% | 53 |
|
|
2019
Q3 | $2.24M | Buy |
8,252
+3,670
| +80% | +$998K | 0.34% | 59 |
|
|
2019
Q2 | $1.26M | Buy |
+4,582
| New | +$1.26M | 0.19% | 74 |
|
|
2017
Q1 | – | Sell |
-9
| Closed | -$1K | – | 516 |
|
|
2016
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 501 |
|